chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Urticaria
Clinical narrative: Hives - 3 or 4 on face; Face was red; Face was hot; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives - 3 or 4 on face), ERYTHEMA (Face was red) and FEELING HOT (Face was hot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Peanut allergy, Food allergy, Fish allergy and Latex allergy. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced URTICARIA (Hives - 3 or 4 on face), ERYTHEMA (Face was red) and FEELING HOT (Face was hot). On 09-Feb-2021, URTICARIA (Hives - 3 or 4 on face), ERYTHEMA (Face was red) and FEELING HOT (Face was hot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: woke up with Migraine and now her Migraine is going lil worse; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (woke up with Migraine and now her Migraine is going lil worse) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event (No medical History Reported).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced MIGRAINE (woke up with Migraine and now her Migraine is going lil worse). At the time of the report, MIGRAINE (woke up with Migraine and now her Migraine is going lil worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment information was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Follow-up received on 15-Apr-2021 date included no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: pressure type pain in upper mid chest area; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pressure type pain in upper mid chest area) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (pressure type pain in upper mid chest area). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (pressure type pain in upper mid chest area) outcome was unknown.            No Concomitant Medications taken were provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product usage were not provided. Treatment details were also not provided.   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Nausea, Pain in extremity, Skin discolouration, Tenderness
Clinical narrative: sore arm; red patch; pink; tender; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (red patch), SKIN DISCOLOURATION (pink), TENDERNESS (tender) and NAUSEA (nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced NAUSEA (nausea). On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), ERYTHEMA (red patch), SKIN DISCOLOURATION (pink) and TENDERNESS (tender). At the time of the report, PAIN IN EXTREMITY (sore arm), ERYTHEMA (red patch), SKIN DISCOLOURATION (pink), TENDERNESS (tender) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Vaccination site pain
Clinical narrative: fast heartbeat; headache; pain; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartbeat), HEADACHE (headache) and VACCINATION SITE PAIN (pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (fast heartbeat), HEADACHE (headache) and VACCINATION SITE PAIN (pain). At the time of the report, HEART RATE INCREASED (fast heartbeat), HEADACHE (headache) and VACCINATION SITE PAIN (pain) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.    Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Myalgia, Skin swelling
Clinical narrative: puffy; itchiness; big, red circle/redness/red spot; arm sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN SWELLING (puffy), INJECTION SITE PRURITUS (itchiness), MYALGIA (arm sore) and INJECTION SITE ERYTHEMA (big, red circle/redness/red spot) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ASCORBIC ACID (VITAMIN C ACID) and ZINC for an unknown indication.    On 17-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced MYALGIA (arm sore). On 24-Feb-2021, the patient experienced SKIN SWELLING (puffy), INJECTION SITE PRURITUS (itchiness) and INJECTION SITE ERYTHEMA (big, red circle/redness/red spot). The patient was treated with HYDROCORTISONE (HYDROCORTISONE 1% IN ABSORBASE) (topical) on 25-Feb-2021 at a dose of twice a day to four times a day and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK UNK, bid. At the time of the report, SKIN SWELLING (puffy), INJECTION SITE PRURITUS (itchiness), MYALGIA (arm sore) and INJECTION SITE ERYTHEMA (big, red circle/redness/red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Malaise, Pain, Pain in extremity
Clinical narrative: Right after the shot I became very dizzy and had to get a ride home. The following day I felt very ill, low grade fever 99.9*F, body aches, sore arm for several days, very weak had to lay down.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Right after the shot I became very dizzy and had to get a ride home. The following day I felt very ill, low grade fever 99.9*F, body aches, sore arm for several days, very weak had to lay down.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Pain, Pain in extremity
Clinical narrative: Woke up the next morning 8.4.21 and could not pick up my head. Neck was stif and stuck to the right side. Right arm is where my shot was given. Took roughly 3 days to be able to pick up my head fully without pain. Arm and neck was in pain when trying to pick up my head.
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Myalgia
Clinical narrative: Lethargy; Sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy) and MYALGIA (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy) and MYALGIA (Sore arm). At the time of the report, LETHARGY (Lethargy) and MYALGIA (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Erythema, Feeling abnormal, Pallor, Pruritus
Clinical narrative: 1 day after my modern vaccine. I almost throw up and my body feel really bad, like when I touch my body it feels really really weird.  Today my entire face is white but my nose is very red and itching none stop. I feel like I had an allergic reaction.  The first day; my body feel bad, I almost throw up, my body temperature was high. Second day: my nose turned red and itchy.. I don't know what's going to happen next.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: ARM PAIN
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Throat tightness
Clinical narrative: Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Systemic: Lymph Node Swelling-Medium
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeding disorder, Flushing, Headache
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: Patient states symtoms started 2 days after receiving vaccination. This caused him to be unable to eat. At this time, he then started to have pain on one side of his neck. He noticed over the next couple of days that he had increased swelling and pain. It has stayed the same size/pain level. He does not have a PCP and is going to wait until the following week to seek care, if needed.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection site pain, Lethargy, Lymphadenopathy, Nausea
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: Patient states symtoms started 2 days after receiving vaccination. This caused him to be unable to eat. At this time, he then started to have pain on one side of his neck. He noticed over the next couple of days that he had increased swelling and pain. It has stayed the same size/pain level. He does not have a PCP and is going to wait until the following week to seek care, if needed.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pain, Sleep disorder, Swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: Patient states symtoms started 2 days after receiving vaccination. This caused him to be unable to eat. At this time, he then started to have pain on one side of his neck. He noticed over the next couple of days that he had increased swelling and pain. It has stayed the same size/pain level. He does not have a PCP and is going to wait until the following week to seek care, if needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dry mouth, Fatigue, Gait disturbance
Clinical narrative: persistent diarrhea; difficulty ambulating; weakness; dry mouth; fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (persistent diarrhea), GAIT DISTURBANCE (difficulty ambulating), ASTHENIA (weakness), DRY MOUTH (dry mouth) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Uterine cancer (C55 UTERINE CANCER). Concomitant products included LENVATINIB MESILATE (LENVIMA) from 13-Nov-2020 to an unknown date for Uterine cancer.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (persistent diarrhea), GAIT DISTURBANCE (difficulty ambulating), ASTHENIA (weakness), DRY MOUTH (dry mouth) and FATIGUE (fatigue). At the time of the report, DIARRHOEA (persistent diarrhea), GAIT DISTURBANCE (difficulty ambulating), ASTHENIA (weakness), DRY MOUTH (dry mouth) and FATIGUE (fatigue) outcome was unknown. Not Provided          On 05-Feb-2021, the patient underwent CT scan with contrast and results were not available. Other relevant history included keytruda infusions. Treatment information was not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: slight pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight pain in the arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (slight pain in the arm). At the time of the report, PAIN IN EXTREMITY (slight pain in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: got around the vaccine area a circle of 3 inches really really red; Vaccine area was slightly itchy; pain in the arm to the touch for two days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm to the touch for two days), VACCINATION SITE ERYTHEMA (got around the vaccine area a circle of 3 inches really really red) and VACCINATION SITE PRURITUS (Vaccine area was slightly itchy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, SIMVASTATIN, CALCIUM and VITAMIN D NOS for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm to the touch for two days). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (got around the vaccine area a circle of 3 inches really really red) and VACCINATION SITE PRURITUS (Vaccine area was slightly itchy). At the time of the report, PAIN IN EXTREMITY (pain in the arm to the touch for two days), VACCINATION SITE ERYTHEMA (got around the vaccine area a circle of 3 inches really really red) and VACCINATION SITE PRURITUS (Vaccine area was slightly itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment medications.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Lip swelling, Mouth swelling, Swelling face, Throat clearing
Clinical narrative: Chest was tight; Swelling in lower lip; Swelling in inner cheek; Swelling on the interior of the mouth; Kept having to clear her throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROAT CLEARING (Kept having to clear her throat), CHEST DISCOMFORT (Chest was tight), LIP SWELLING (Swelling in lower lip), SWELLING FACE (Swelling in inner cheek) and MOUTH SWELLING (Swelling on the interior of the mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced THROAT CLEARING (Kept having to clear her throat), LIP SWELLING (Swelling in lower lip), SWELLING FACE (Swelling in inner cheek) and MOUTH SWELLING (Swelling on the interior of the mouth). On 05-Feb-2021, the patient experienced CHEST DISCOMFORT (Chest was tight). At the time of the report, THROAT CLEARING (Kept having to clear her throat), CHEST DISCOMFORT (Chest was tight), LIP SWELLING (Swelling in lower lip) and SWELLING FACE (Swelling in inner cheek) had not resolved and MOUTH SWELLING (Swelling on the interior of the mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The pharmacist suggested the patient to drink water, after 30 minutes the patient went emergency room. The patient needed to use the nebulizer and her doctor prescriber her prednisone. Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: No new information
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Vertigo. Concurrent medical conditions included Seasonal allergy.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not reported.   This case was linked to MOD-2021-240635 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received: Contain Non- significant information.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea, Sneezing
Clinical narrative: sneezing; runny nose,clear nasal discharge; dry cough; A spontaneous report was received from a consumer concerning a 79 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sneezing, runny nose, clear nasal discharge/ rhinorrhea, dry cough/ cough.  The patient's medical history was not provided. Concomitant medications taken by the patient were not provided.  On an unknown date, prior to the onset of the event, the patient received first of their two planned doses of mRNA-1273 (Lot number: unknown) through unknown route at unspecified site for prophylaxis of COVID-19 infection.  On 27 Feb 2021, prior to the onset of the event, the patient received second of their two planned doses of mRNA-1273 (Lot number: 011A21A) through intramuscular route at unspecified site for prophylaxis of COVID-19 infection.  On 27 Feb 2021, patient experienced sneezing, runny nose, dry cough, clear nasal discharge.  Treatment activities for event was unknown.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events, sneezing, runny nose, dry cough, clear nasal discharge was unknown.; Sender's Comments:  MOD-2021-029946:cross link, husband's case
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia
Clinical narrative: covid-19; fever; flu symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced COVID-19 (covid-19).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Swelling face
Clinical narrative: Swelling at face and extremities; Swelling at face and extremities; All over the body is itchy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 072A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy). At the time of the report, SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Flushing
Clinical narrative: Flushing on face like sunburn; Ears fill full; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing on face like sunburn) and EAR DISCOMFORT (Ears fill full) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FLUSHING (Flushing on face like sunburn) and EAR DISCOMFORT (Ears fill full). At the time of the report, FLUSHING (Flushing on face like sunburn) and EAR DISCOMFORT (Ears fill full) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Eye pain, Headache, Nasal congestion, Pyrexia
Clinical narrative: fever; eyes hurt; stuffy nose; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), EYE PAIN (eyes hurt), NASAL CONGESTION (stuffy nose) and HEADACHE (slight headache) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (fever), EYE PAIN (eyes hurt), NASAL CONGESTION (stuffy nose) and HEADACHE (slight headache). At the time of the report, PYREXIA (fever), EYE PAIN (eyes hurt), NASAL CONGESTION (stuffy nose) and HEADACHE (slight headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 100.3 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Patient reports for the last 10 days my temperature has been in the 97 degrees range. Currently it is 100.3 degrees.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Bradyphrenia
Clinical narrative: Felt a little bit sluggish; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BRADYPHRENIA (Felt a little bit sluggish) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 25-Feb-2021, the patient experienced BRADYPHRENIA (Felt a little bit sluggish). On 26-Feb-2021, BRADYPHRENIA (Felt a little bit sluggish) had resolved.            This case was linked to MOD-2021-030380 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Lymphadenopathy
Clinical narrative: fatigue; headache; chills; joint pain; swelling lymph node; injection site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain). On 26-Feb-2021, CHILLS (chills) outcome was unknown. At the time of the report, ARTHRALGIA (joint pain) outcome was unknown and LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-027396.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: fatigue; headache; chills; joint pain; swelling lymph node; injection site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain). On 26-Feb-2021, CHILLS (chills) outcome was unknown. At the time of the report, ARTHRALGIA (joint pain) outcome was unknown and LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-027396.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Eructation, Fatigue, Nausea
Clinical narrative: Belching; Diarrhea; Fatigue; Chills; Nausea; Vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, LOVASTATIN and VITAMIN 15.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting). On 27-Feb-2021, ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Belching; Diarrhea; Fatigue; Chills; Nausea; Vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, LOVASTATIN and VITAMIN 15.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting). On 27-Feb-2021, ERUCTATION (Belching), DIARRHOEA (Diarrhea), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: neck pain; fatigue; nausea; chills; headache; pain around the injection site; arthralgia; general myalgias; This spontaneous case was reported by a physician and describes the occurrence of NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias) and FATIGUE (fatigue) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia) and MYALGIA (general myalgias). On an unknown date, the patient experienced NECK PAIN (neck pain), FATIGUE (fatigue), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache). At the time of the report, NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache) had resolved and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided   This case was linked to MOD-2021-045901 (Patient Link).
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Vaccination site pain
Clinical narrative: neck pain; fatigue; nausea; chills; headache; pain around the injection site; arthralgia; general myalgias; This spontaneous case was reported by a physician and describes the occurrence of NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias) and FATIGUE (fatigue) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia) and MYALGIA (general myalgias). On an unknown date, the patient experienced NECK PAIN (neck pain), FATIGUE (fatigue), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache). At the time of the report, NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache) had resolved and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided   This case was linked to MOD-2021-045901 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeding; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nose bleeding) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.   Concomitant products included WARFARIN SODIUM (COUMADIN), HYDROCHLOROTHIAZIDE, SPIRONOLACTONE (ALDACTONE 50 HCT) and LOSARTAN POTASSIUM (COZARIL) for an unknown indication.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (Nose bleeding). At the time of the report, EPISTAXIS (Nose bleeding) had resolved.      No treatment information was provided. The patient had nose bleeding 5 times after the first dose and twice she had to go to the emergency. She had the 2nd dose also without any repeat of nose bleeding or other issues. The patient was fine.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: the outcome of the event was updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: itchiness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itchiness at site of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at site of injection). The patient was treated with PREDNISONE on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency and PEPTIDES NOS on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency. On 05-Feb-2021, INJECTION SITE PRURITUS (itchiness at site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Body temperature increased, Influenza like illness, Myalgia
Clinical narrative: stomach hurts; feels like she has the flu; 98.7F temperature; I am in a lot of pain; whole body is aching; especially ache in knee joins; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain) and MYALGIA (whole body is aching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain), MYALGIA (whole body is aching) and ARTHRALGIA (especially ache in knee joins). At the time of the report, ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain), MYALGIA (whole body is aching) and ARTHRALGIA (especially ache in knee joins) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: stomach hurts; feels like she has the flu; 98.7F temperature; I am in a lot of pain; whole body is aching; especially ache in knee joins; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain) and MYALGIA (whole body is aching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain), MYALGIA (whole body is aching) and ARTHRALGIA (especially ache in knee joins). At the time of the report, ABDOMINAL PAIN UPPER (stomach hurts), INFLUENZA LIKE ILLNESS (feels like she has the flu), BODY TEMPERATURE INCREASED (98.7F temperature), PAIN (I am in a lot of pain), MYALGIA (whole body is aching) and ARTHRALGIA (especially ache in knee joins) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Menstrual cycle management, Pain
Clinical narrative: Body Aches; Lower Back Pain; menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Aches), BACK PAIN (Lower Back Pain) and MENSTRUAL CYCLE MANAGEMENT (menstrual cycle) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body Aches), BACK PAIN (Lower Back Pain) and MENSTRUAL CYCLE MANAGEMENT (menstrual cycle). At the time of the report, PAIN (Body Aches), BACK PAIN (Lower Back Pain) and MENSTRUAL CYCLE MANAGEMENT (menstrual cycle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Flushing, Injection site pain, Nausea
Clinical narrative: uncontrollable chills; severe dry heaves; felt flushed; shoulder feels like a frozen shoulder; pain in my arm where I got the injection; Nausea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (felt flushed), PERIARTHRITIS (shoulder feels like a frozen shoulder), ASTHENIA (weakness), RETCHING (severe dry heaves) and NAUSEA (nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  The patient's past medical history included COVID-19 on 16-Jan-2021. Concurrent medical conditions included Coronary artery disease. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FLUSHING (felt flushed), ASTHENIA (weakness), NAUSEA (nausea) and CHILLS (uncontrollable chills). On 12-Feb-2021, the patient experienced RETCHING (severe dry heaves). On 17-Feb-2021, the patient experienced PERIARTHRITIS (shoulder feels like a frozen shoulder) and INJECTION SITE PAIN (pain in my arm where I got the injection). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 11-Feb-2021, FLUSHING (felt flushed), ASTHENIA (weakness), NAUSEA (nausea) and CHILLS (uncontrollable chills) had resolved. At the time of the report, PERIARTHRITIS (shoulder feels like a frozen shoulder), RETCHING (severe dry heaves) and INJECTION SITE PAIN (pain in my arm where I got the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, SARS-CoV-2 test (positive-negative): positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Periarthritis, Retching, SARS-CoV-2 test
Clinical narrative: uncontrollable chills; severe dry heaves; felt flushed; shoulder feels like a frozen shoulder; pain in my arm where I got the injection; Nausea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (felt flushed), PERIARTHRITIS (shoulder feels like a frozen shoulder), ASTHENIA (weakness), RETCHING (severe dry heaves) and NAUSEA (nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  The patient's past medical history included COVID-19 on 16-Jan-2021. Concurrent medical conditions included Coronary artery disease. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FLUSHING (felt flushed), ASTHENIA (weakness), NAUSEA (nausea) and CHILLS (uncontrollable chills). On 12-Feb-2021, the patient experienced RETCHING (severe dry heaves). On 17-Feb-2021, the patient experienced PERIARTHRITIS (shoulder feels like a frozen shoulder) and INJECTION SITE PAIN (pain in my arm where I got the injection). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 11-Feb-2021, FLUSHING (felt flushed), ASTHENIA (weakness), NAUSEA (nausea) and CHILLS (uncontrollable chills) had resolved. At the time of the report, PERIARTHRITIS (shoulder feels like a frozen shoulder), RETCHING (severe dry heaves) and INJECTION SITE PAIN (pain in my arm where I got the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, SARS-CoV-2 test (positive-negative): positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.